Ann: Race Oncology Board Renewal Update, page-64

C'mon, Ralom. This isn't your first rodeo.

Nothing personal against Phil or Mary (and even JC and DCB who were ousted a year ago). But this is a change that needed to happen. It was clear from numerous board actions that they weren't aligned with shareholders.

This was apparent even in conversation at AGMs and investor presentations. Pete is energised and excited. Past members have been unenthusiastic and complacent (if not completely absent).

The likelihood of RAC extracting maximum value out of Zantrene just increased dramatically. Non holders still not realising this is one of the best announcements we've received all year...